Tsuchihashi, K., Ito, M., Okumura, Y., Nio, K., Ozaki, Y., Nishio, H., Ichihara, E., Miura, Y., Endo, M., Yano, S., Maruyama, D., Yoshinami, T., Susumu, N., Takekuma, M., Motohashi, T., Ochi, N., Kubo, T., Uchino, K., Kimura, T., Kamiyama, Y., … Baba, E. (2024). Therapeutic use of granulocyte colony-stimulating factor (G-CSF) in patients with febrile neutropenia: A comprehensive systematic review for clinical practice guidelines for the use of G-CSF 2022 from the Japan Society of Clinical Oncology. International Journal of Clinical Oncology, 29(6), 700–705. https://doi.org/10.1007/s10147-024-02541-z
Uchino, K., Tamura, S., Kimura, S., Shigeta, K., Kimura, T., Ozaki, Y., Nishio, H., Tsuchihashi, K., Ichihara, E., Endo, M., Yano, S., Maruyama, D., Yoshinami, T., Susumu, N., Takekuma, M., Motohashi, T., Ito, M., Baba, E., Ochi, N., Kubo, T., … Miura, Y. (2024). Effectiveness and safety of primary prophylaxis of granulocyte colony-stimulating factor during dose-dense chemotherapy for urothelial cancer: Clinical Practice Guidelines for the Use of G-CSF 2022. International Journal of Clinical Oncology, 29(5), 545–550. https://doi.org/10.1007/s10147-024-02491-6